Impact of paraaortic lymphadenectomy for endometrial cancer with positive pelvic lymph nodes: A Korean Radiation Oncology Group study (KROG 13-17).

[1]  C. Aquino-Parsons,et al.  Stage IIIC Endometrial Cancer: Relapse and Survival Outcomes in Women Treated With Pelvic or Extended Field Para-Aortic Nodal Radiation Therapy , 2017, American journal of clinical oncology.

[2]  T. Ignatov,et al.  Survival advantage of lymphadenectomy in endometrial cancer , 2016, Journal of Cancer Research and Clinical Oncology.

[3]  Young Seok Kim,et al.  A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17). , 2015, Gynecologic oncology.

[4]  S. You,et al.  Impact of lymphadenectomy in uterine endometrioid carcinoma. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  Jason D. Wright,et al.  Comparative Performance of the 2009 International Federation of Gynecology and Obstetrics' Staging System for Uterine Corpus Cancer. , 2011, Obstetrics and gynecology.

[6]  J. Dungan.  Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis , 2011 .

[7]  L. Ramondetta,et al.  Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation. , 2009, Gynecologic oncology.

[8]  M. Parmar,et al.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.

[9]  S. Yamada.  Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study , 2007 .

[10]  J. Chan,et al.  Therapeutic role of lymph node resection in endometrioid corpus cancer , 2006, Cancer.

[11]  Y. Taketani,et al.  Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas. , 2002, Cancer Letters.

[12]  A. Mundt,et al.  Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy. , 2001, International journal of radiation oncology, biology, physics.

[13]  G. Sutton,et al.  FIGO Stage IIIC Endometrial Carcinoma With Metastases Confined to Pelvic Lymph Nodes: Analysis of Treatment Outcomes, Prognostic Variables, and Failure Patterns Following Adjuvant Radiation Therapy , 2000 .

[14]  J. Schorge,et al.  The effect of postsurgical therapy on stage III endometrial carcinoma. , 1996, Gynecologic oncology.

[15]  B. Corn,et al.  Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence , 1993, Cancer.